Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Incontinence and Ostomy Care Products Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Incontinence and Ostomy Care Products Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Incontinence and Ostomy Care Products: Type Estimates & Trend Analysis
4.1. Incontinence and Ostomy Care Products Market, Key Takeaways
4.2. Incontinence and Ostomy Care Products Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Incontinence Care Products
4.3.1. Incontinence care products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Absorbents
4.3.2.1. Absorbents market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Incontinence bags
4.3.3.1. Incontinence bags market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Others
4.3.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Ostomy Care Products
4.4.1. Ostomy care products market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Ostomy bags
4.4.2.1. Ostomy bags market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Deodorants
4.4.3.1. Deodorants market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Skin barriers
4.4.4.1. Skin barriers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Irrigation products
4.4.5.1. Irrigation products market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Incontinence and Ostomy Care Products Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Incontinence and Ostomy Care Products Market by Region: Key Takeaways
5.3. North America
5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.3.2. U.S.
5.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.3.3. Canada
5.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.2. Germany
5.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.3. France
5.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.4. Italy
5.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.5. Spain
5.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.6. Denmark
5.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.7. Sweden
5.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.4.8. Norway
5.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.2. China
5.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.3. India
5.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.4. Australia
5.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.5. Thailand
5.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.5.6. South Korea
5.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.6. Latin America
5.6.1. Brazil
5.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.6.2. Mexico
5.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.6.3. Argentina
5.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7. MEA
5.7.1. South Africa
5.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7.2. Saudi Arabia
5.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7.3. UAE
5.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
5.7.4. Kuwait
5.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Coloplast A/S
6.2.1.1. Company overview
6.2.1.2. Financial performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic initiatives
6.2.2. Essity Aktiebolag (publ).
6.2.2.1. Company overview
6.2.2.2. Financial performance
6.2.2.3. Product benchmarking
6.2.2.4. Strategic initiatives
6.2.3. KCWW (Kimberly-Clark Corporation)
6.2.3.1. Company overview
6.2.3.2. Financial performance
6.2.3.3. Product benchmarking
6.2.3.4. Strategic initiatives
6.2.4. B. Braun SE
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. Hollister Incorporated
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Unicharm Corporation
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. ConvaTec Group Plc
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Welland Medical Limited.
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Domtar Corporation
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
6.2.10. Salts Healthcare Ltd.
6.2.10.1. Company overview
6.2.10.2. Financial performance
6.2.10.3. Product benchmarking
6.2.10.4. Strategic initiatives
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
